Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male Subjects

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of the study is to characterize the absorption, distribution, metabolism, and excretion (ADME) of a single oral dose of \[14C\]PF-05221304 in Healthy Adult Male Subjects

Key facts

Study ID

NCT03448172

Run by

Pfizer

People needed

6

Starts

2018-04-18

Expected to finish

2018-06-13

Last updated by the study team

2018-12-04

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Ages of 18 and 45 years, inclusive.
• Body mass index (BMI) of >= 17.5 and <= 30.4 kg/m2
• Total body weight > 50 kg (110 lb).

You may not qualify if…

• Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurological, allergic disease or clinical findings.

Where it is running

• Covance Clinical Research Unit Inc. — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.